Scholarlink

Background <p>Coronavirus disease-19 infection can exacerbate preexisting chronic heart failure, even after mild illness. This report describes a patient with preexisting dilated cardiomyopathy who developed worsening biventricular failure following recurrent coronavirus disease-19 infections and subsequently improved after intermittent intravenous calcium sensitizer therapy.</p> Case presentation <p>A 37-year-old Indonesian man with advanced heart failure presented with progressive right ventricular dysfunction and worsening pulmonary hypertension after a second mild coronavirus disease-19 infection. Comprehensive phenotyping and risk stratification were performed using multimodality assessment. The patient received intermittent intravenous levosimendan infusion in addition to optimized guideline-directed medical therapy, resulting in marked clinical, hemodynamic, and biomarker improvement.</p> Conclusion <p>Managing advanced heart failure with mixed-type pulmonary hypertension. Following coronavirus disease-19 infection remains a complex clinical challenge. This case contributes to the growing evidence supporting the potential role of levosimendan as adjunctive therapy in managing post-coronavirus disease mixed-type pulmonary hypertension with intractable congestion and biventricular failure.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The potential effect of calcium sensitizer in pulmonary hypertension post-coronavirus disease-19 infection in presumptive familial dilated cardiomyopathy: a case report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月5日

查看全文
  • Dya Pratama Andryan,
  • Dian Yaniarti Hasanah,
  • Celly Anantaria Atmadikoesoemah

摘要

Background

Coronavirus disease-19 infection can exacerbate preexisting chronic heart failure, even after mild illness. This report describes a patient with preexisting dilated cardiomyopathy who developed worsening biventricular failure following recurrent coronavirus disease-19 infections and subsequently improved after intermittent intravenous calcium sensitizer therapy.

Case presentation

A 37-year-old Indonesian man with advanced heart failure presented with progressive right ventricular dysfunction and worsening pulmonary hypertension after a second mild coronavirus disease-19 infection. Comprehensive phenotyping and risk stratification were performed using multimodality assessment. The patient received intermittent intravenous levosimendan infusion in addition to optimized guideline-directed medical therapy, resulting in marked clinical, hemodynamic, and biomarker improvement.

Conclusion

Managing advanced heart failure with mixed-type pulmonary hypertension. Following coronavirus disease-19 infection remains a complex clinical challenge. This case contributes to the growing evidence supporting the potential role of levosimendan as adjunctive therapy in managing post-coronavirus disease mixed-type pulmonary hypertension with intractable congestion and biventricular failure.